These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 25668264)

  • 1. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
    Emdin CA; Rahimi K; Neal B; Callender T; Perkovic V; Patel A
    JAMA; 2015 Feb; 313(6):603-15. PubMed ID: 25668264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
    Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
    Ettehad D; Emdin CA; Kiran A; Anderson SG; Callender T; Emberson J; Chalmers J; Rodgers A; Rahimi K
    Lancet; 2016 Mar; 387(10022):957-967. PubMed ID: 26724178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intensive blood pressure lowering on mortality and cardiovascular and renal outcomes in type 2 diabetic patients: A meta-analysis.
    Wang J; Chen Y; Xu W; Lu N; Cao J; Yu S
    PLoS One; 2019; 14(4):e0215362. PubMed ID: 30978254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels: A Systematic Review and Meta-analysis.
    Brunström M; Carlberg B
    JAMA Intern Med; 2018 Jan; 178(1):28-36. PubMed ID: 29131895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular outcomes in patients with diabetes when initiating blood pressure lowering at baseline SBP between 130 and 140 mm Hg: A meta-analysis.
    Wang S; Djama NM; Lai Y; Li H; Liao W; Liao Y; Bin J
    J Clin Hypertens (Greenwich); 2019 Feb; 21(2):220-229. PubMed ID: 30637947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
    Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
    PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
    Nazarzadeh M; Bidel Z; Canoy D; Copland E; Bennett DA; Dehghan A; Davey Smith G; Holman RR; Woodward M; Gupta A; Adler AI; Wamil M; Sattar N; Cushman WC; McManus RJ; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
    Lancet Diabetes Endocrinol; 2022 Sep; 10(9):645-654. PubMed ID: 35878651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
    Lv J; Neal B; Ehteshami P; Ninomiya T; Woodward M; Rodgers A; Wang H; MacMahon S; Turnbull F; Hillis G; Chalmers J; Perkovic V
    PLoS Med; 2012; 9(8):e1001293. PubMed ID: 22927798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses.
    Brunström M; Carlberg B
    BMJ; 2016 Feb; 352():i717. PubMed ID: 26920333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment blood pressure targets for hypertension.
    Arguedas JA; Perez MI; Wright JM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD004349. PubMed ID: 19588353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
    Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
    PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.
    Malhotra R; Nguyen HA; Benavente O; Mete M; Howard BV; Mant J; Odden MC; Peralta CA; Cheung AK; Nadkarni GN; Coleman RL; Holman RR; Zanchetti A; Peters R; Beckett N; Staessen JA; Ix JH
    JAMA Intern Med; 2017 Oct; 177(10):1498-1505. PubMed ID: 28873137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intensive lowering of systolic blood pressure treatment on heart failure events: a meta-analysis of randomized controlled studies.
    Zhang Y; Liang M; Sun C; Qu G; Shi T; Min M; Wu Y; Sun Y
    J Hum Hypertens; 2019 Sep; 33(9):648-657. PubMed ID: 31363149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive Agents in Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Murad MH; Larrea-Mantilla L; Haddad A; Spencer-Bonilla G; Serrano V; Rodriguez-Gutierrez R; Alvarez-Villalobos N; Benkhadra K; Gionfriddo MR; Prokop LJ; Brito JP; Ponce OJ
    J Clin Endocrinol Metab; 2019 May; 104(5):1575-1584. PubMed ID: 30903690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2014 Dec; 32(12):2285-95. PubMed ID: 25255397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.